+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of taurine on febrile episodes in acute lymphoblastic leukemia

Advanced Pharmaceutical Bulletin 5(1): 103-108
Effect of taurine on febrile episodes in acute lymphoblastic leukemia
The purpose of our study was to evaluate the effect of oral taurine on the incidence of febrile episodes during chemotherapy in young adults with acute lymphoblastic leukemia. Forty young adults with acute lymphoblastic leukemia, at the beginning of maintenance course of their chemotherapy, were eligible for this study. The study population was randomized in a double blind manner to receive either taurine or placebo (2 gram per day orally). Life quality and side effects including febrile episodes were assessed using questionnaire. Data were analyzed using Pearson's Chi square test. Of total forty participants, 43.8% were female and 56.3 % were male. The mean age was 19.16±1.95 years (ranges: 16-23 years). The results indicated that the levels of white blood cells are significantly (P<0.05) increased in taurine treated group. There was no elevation in blasts count. A total of 70 febrile episodes were observed during study, febrile episodes were significantly (P<0.05) lower in taurine patients in comparison to the control ones. The overall incidence of febrile episodes and infectious complications in acute lymphoblastic leukemia patients receiving taurine was lower than placebo group. Taurine's ability to increase leukocyte count may result in lower febrile episodes.

(PDF same-day service: $19.90)

Accession: 057710677

PMID: 25789226

DOI: 10.5681/apb.2015.014

Related references

Characterization of episodes of febrile neutropenia in children with acute myeloid leukemia and acute lymphoblastic leukemia. Revista Chilena de Infectologia 31(3): 333-338, 2015

Prediction of bacteremia in children with febrile episodes during chemotherapy for acute lymphoblastic leukemia. Pediatric Hematology and Oncology 30(2): 131-140, 2013

Infections in childhood acute lymphoblastic leukemia: an analysis of 222 febrile neutropenic episodes. Pediatric Hematology and Oncology 25(5): 385-392, 2008

Effect of taurine on attenuating chemotherapy-induced adverse effects in acute lymphoblastic leukemia. Journal of Cancer Research and Therapeutics 11(2): 426-432, 2016

Febrile neutropenia in acute myeloid leukemia an analysis of 110 episodes treated with or without G-CSF A report of the Buenos Aires Leukemia Group. Blood 86(10 SUPPL 1): 783A, 1995

Effect of honey on febrile neutropenia in children with acute lymphoblastic leukemia: A randomized crossover open-labeled study. Complementary Therapies in Medicine 25(): 98-103, 2016

Infections in acute leukemia: an analysis of 240 febrile episodes. Medical Oncology 17(2): 111-116, 2000

Infections in acute myeloid leukemia. Study of 184 febrile episodes. Journal of the Association of Physicians of India 40(1): 18-20, 1992

Infections in acute myeloid leukemia: an analysis of 382 febrile episodes. Medical Oncology 27(4): 1037-1045, 2011

Assessment of febrile neutropenia episodes in children with acute leukemia treated with BFM protocols. Pediatric Hematology and Oncology 25(3): 195-204, 2008